National surveillance of dialysis-associated diseases in the United States, 1997.
Tokars
J I
JI
National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. jit1@cdc.gov
Miller
E R
ER
Alter
M J
MJ
Arduino
M J
MJ
D016470:Bacteremia / Q000453:epidemiology / Q000209:etiology; D002487:Centers for Disease Control and Prevention, U.S.; D003428:Cross Infection / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D004352:Drug Resistance, Microbial; D016983:Enterococcus / Q000187:drug effects; D017743:Equipment Reuse; D015658:HIV Infections / Q000453:epidemiology / Q000209:etiology; D006509:Hepatitis B / Q000453:epidemiology / Q000209:etiology; D006526:Hepatitis C / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D015994:Incidence; D016106:Methicillin Resistance; D011159:Population Surveillance; D015995:Prevalence; D006435:Renal Dialysis / Q000009:adverse effects*; D013211:Staphylococcus aureus / Q000187:drug effects; D011795:Surveys and Questionnaires; D014376:Tuberculosis / Q000453:epidemiology / Q000209:etiology; D014481:United States; D014640:Vancomycin / Q000494:pharmacology
D014640:Vancomycin